Status:
UNKNOWN
Cardiovascular Disease Risk of Awareness
Lead Sponsor:
Necmettin Erbakan University
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The Cardiovascular Risk Reduction Program (CARDIOREP) aims to raise risk awareness and reduce risk factors.
Detailed Description
While 1/3 of premature deaths in individuals under the age of 70 in the world occur due to Cardiovascular Diseases (WHO 2022), circulatory system diseases are at the forefront with 36.76% according to...
Eligibility Criteria
Inclusion
- Not having been diagnosed with cardiovascular disease.
- Using a smartphone.
- Agree to use the Google Fit App.
Exclusion
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06000436
Start Date
November 1 2023
End Date
March 1 2024
Last Update
November 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.